Investigative Ophthalmology & Visual Science Cover Image for Volume 60, Issue 9
July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Delayed onset Scleromalacia following intraoperative Mitomycin C application for Conjunctival Melanoma
Author Affiliations & Notes
  • Syed Shahid
    Ophthalmology , Moorfields Eye Hospital, Eastbourne , United Kingdom
  • Syed Naqib Ahmed
    Ophthalmology, East Sussex Healthcare Trust, United Kingdom
  • Mayank Nanavaty
    Ophthalmology, Brighton and Sussex University Hospital NHS Trust, Brighton, United Kingdom
  • Footnotes
    Commercial Relationships   Syed Shahid, None; Syed Ahmed, None; Mayank Nanavaty, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3561. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Syed Shahid, Syed Naqib Ahmed, Mayank Nanavaty; Delayed onset Scleromalacia following intraoperative Mitomycin C application for Conjunctival Melanoma. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3561.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To present a case of delayed scleromalacia one year after conjunctival melanoma excision with mitomycin-C (MMC) therapy and double freeze-thaw technique.

Methods : Case report

Results : A 69-year-old lady had a conjunctival melanoma excised by the ‘no touch technique’ with intraoperative MMC, freeze-thaw cryotherapy and amniotic membrane transplant elsewhere. Three months later she presented to our ophthalmology unit with a red, sore and painful right eye. Examination revealed severe scleritis. She was treated with lubricants and oral steroids for six weeks. She settled well with no recurrence of melanoma. At one year she developed scleromalacia and conjunctival blebs in the inferonasal quadrant of the right eye.

Conclusions : Severe caution should be exercised with the use of intraoperative MMC during excision and cryotherapy of conjunctival melanoma. When using MMC, it would be recommended to use the lowest dose topically in the form of eye drops postoperatively for the shortest time, to avoid any sight-threatening complications. Our case, was a rare example that scleral thinning can occur post scleral dissection and MMC use for an ocular surface neoplasia.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×